|
|
|
|
|
Last Trade
|
Last Trade:
$0.81
|
Change:
-0.005 (-0.61%)
|
Trade Time:
Dec 06
|
Market Cap:
$15.94M
|
|
|
|
|
|
|
Description of Business
|
|
The terms "we," "us," "our," "Daré" or the "Company" refer collectively to Daré
Bioscience, Inc. and its wholly-owned subsidiaries, unless otherwise stated or
the context otherwise requires. All information in this report is based on our
fiscal year. Unless otherwise stated, references to particular years, quarters,
months or periods refer to our fiscal years ending December 31 and the
associated quarters, months and periods of those fiscal years.
Overview
We are a clinical-stage biopharmaceutical company committed to the advancement
of innovative products for women's health. We are driven by a mission to
identify, develop and bring to market a diverse portfolio of differentiated
therapies that expand treatment options, improve outcomes and facilitate
convenience for women, primarily in the areas of contraception, vaginal health,
sexual health and fertility.
|
|
|
|